A randomized controlled trial of an oral probiotic to reduce antepartum group B Streptococcus colonization and gastrointestinal symptoms is a research paper published in American Journal of Obstetrics & Gynecology MFM (2022). On theSindex it has a DataRank of 0.442. It has been cited 18 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.442
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Eunice Kennedy Shriver National Institute of Child Health and Human Development
Grant: R21HD095320
National Institutes of Health
MeSH Terms
Keywords